News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
20-Aug-2008 - Men with signs of benign prostatic hyperplasia (BPH) can be helped with a daily dose of tadalafil (Cialis®) to relieve associated lower urinary tract symptoms (LUTS), according to a new study published in The Journal of Urology. Researchers from the University of Texas Southwestern Medical ...
19-Aug-2008 - The U.S. Food and Drug Administration approved tetrabenazine, the first drug approved for use in the United States to treat Huntington’s disease. The action comes about eight months after an advisory panel unanimously voted to advise FDA to make the medication available to treat the disease. The ...
19-Aug-2008 - SymBio Pharmaceuticals Limited. and Eisai Co., Ltd. announced that the companies have concluded the license agreement for the co-development and commercialization of bendamustine hydrochloride in Japan, with exclusive rights retained by SymBio. Based on this agreement, SymBio shall grant ...
19-Aug-2008 - Onyx Pharmaceuticals, Inc. announced the appointment of Dr. Juergen Lasowski as senior vice president of corporate development. In this role, Dr. Lasowski will lead business development activities for the company, assessing opportunities to potentially expand and diversify Onyx's ...
19-Aug-2008 - MedMira Inc. announced that it has entered in to an agreement in principal with an investor for the issuance of a CDN $650,000 convertible debenture. Under the terms of the agreement, the debenture will bear interest of 9% per annum and will mature four years from the date of close. The ...
18-Aug-2008 - Antisoma plc announced survival data from its phase II study of ASA404 in hormone-refractory prostate cancer, in which patients were randomised to receive either 1200 mg/m2 ASA404 plus the chemotherapy drug docetaxel or a control treatment of docetaxel alone. The hazard ratio expressing the ...
18-Aug-2008 - Santhera Pharmaceuticals announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to SNT-317/omigapil for treatment of Congenital Muscular Dystrophy. This severe, genetically determined neuromuscular condition frequently affects infants or young children with ...
18-Aug-2008 - QSV Biologics, Ltd (QSV) and Critical Biologics Corp. (CBC) announced the signing of a second, repeat business, contract for the cGMP manufacturing of recombinant human plasma gelsolin (Solinex(TM)) being targeted for various critical care applications and end-stage renal disease patients on ...
18-Aug-2008 - Immunocorp Animal Health AS (IAH), a wholly owned subsidiary of Biotec Pharmacon ASA, has been awarded a major research and development contract by the European Commission. The contract will be undertaken by nine partners from Norway, the Netherlands, Denmark, England, Germany and Poland and is ...
Milestone triggers $10 million payment from Eli Lilly and Company
15-Aug-2008 - BioMS Medical Corp. announced that the independent Drug Safety Monitoring Board (DSMB) for the MAESTRO-01 trial has conducted the scheduled interim analysis of efficacy and safety and has recommended that the trial continue to completion. MAESTRO-01 is the pivotal phase II/III Canadian and ...
© 1997-2024 LUMITOS AG, All rights reserved